Isabelle Sermet‐Gaudelus

18.5k total citations · 5 hit papers
259 papers, 10.1k citations indexed

About

Isabelle Sermet‐Gaudelus is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Isabelle Sermet‐Gaudelus has authored 259 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Pulmonary and Respiratory Medicine, 43 papers in Epidemiology and 39 papers in Molecular Biology. Recurrent topics in Isabelle Sermet‐Gaudelus's work include Cystic Fibrosis Research Advances (191 papers), Neonatal Respiratory Health Research (82 papers) and Tracheal and airway disorders (43 papers). Isabelle Sermet‐Gaudelus is often cited by papers focused on Cystic Fibrosis Research Advances (191 papers), Neonatal Respiratory Health Research (82 papers) and Tracheal and airway disorders (43 papers). Isabelle Sermet‐Gaudelus collaborates with scholars based in France, United States and United Kingdom. Isabelle Sermet‐Gaudelus's co-authors include Jane C. Davies, Félix Ratjen, G. Lenoir, Kevin W Southern, Aleksander Edelman, Scott C. Bell, À. Munck, Steven M. Rowe, Michael W. Konstan and Claire Wainwright and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Isabelle Sermet‐Gaudelus

241 papers receiving 10.0k citations

Hit Papers

A CFTR Potentiator in Patients with Cystic Fibrosis and t... 2011 2026 2016 2021 2011 2017 2014 2015 2015 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
    2011 1.5k citations Isabelle Sermet‐Gaudelus et al. profile →
  2. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
    2017 566 citations Philip M. Farrell, Terry B. White et al. profile →
  3. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
    2014 371 citations Isabelle Sermet‐Gaudelus, Kevin W Southern et al. Journal of Cystic Fibrosis profile →
  4. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
    2015 360 citations Sarah E. Hempstead, Isabelle Sermet‐Gaudelus et al. Thorax profile →
  5. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
    2015 303 citations Sarah E. Hempstead, Isabelle Sermet‐Gaudelus et al. Thorax profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Sermet‐Gaudelus France 49 6.8k 1.9k 1.6k 1.0k 897 259 10.1k
Bruce C. Marshall United States 52 10.0k 1.5× 2.5k 1.4× 1.5k 0.9× 746 0.7× 943 1.1× 138 13.2k
Eitan Kerem Israel 50 7.1k 1.0× 1.4k 0.7× 1.8k 1.1× 490 0.5× 1.1k 1.2× 263 10.0k
Diana Bilton United Kingdom 47 6.0k 0.9× 1.9k 1.0× 683 0.4× 710 0.7× 647 0.7× 199 7.9k
Ronald L. Gibson United States 47 6.9k 1.0× 2.4k 1.3× 2.5k 1.5× 967 1.0× 738 0.8× 130 9.8k
James R. Yankaskas United States 53 6.7k 1.0× 1.1k 0.6× 3.5k 2.2× 520 0.5× 965 1.1× 103 10.8k
Frank J. Accurso United States 57 9.9k 1.5× 1.8k 1.0× 2.0k 1.2× 425 0.4× 1.3k 1.5× 191 12.5k
Noel G. McElvaney Ireland 74 8.7k 1.3× 1.8k 1.0× 4.6k 2.8× 1.3k 1.2× 1.9k 2.1× 360 17.8k
Patrick A. Flume United States 47 7.8k 1.2× 1.7k 0.9× 1.0k 0.6× 504 0.5× 800 0.9× 241 9.6k
Félix Ratjen Canada 65 14.9k 2.2× 2.2k 1.2× 2.5k 1.5× 832 0.8× 2.8k 3.1× 452 18.1k
Michael W. Konstan United States 71 15.2k 2.2× 2.2k 1.2× 2.5k 1.5× 516 0.5× 2.2k 2.4× 243 18.0k

Countries citing papers authored by Isabelle Sermet‐Gaudelus

Since Specialization
Citations

This map shows the geographic impact of Isabelle Sermet‐Gaudelus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Sermet‐Gaudelus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Sermet‐Gaudelus more than expected).

Fields of papers citing papers by Isabelle Sermet‐Gaudelus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Sermet‐Gaudelus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Sermet‐Gaudelus. The network helps show where Isabelle Sermet‐Gaudelus may publish in the future.

Co-authorship network of co-authors of Isabelle Sermet‐Gaudelus

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Sermet‐Gaudelus. A scholar is included among the top collaborators of Isabelle Sermet‐Gaudelus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Sermet‐Gaudelus. Isabelle Sermet‐Gaudelus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sermet‐Gaudelus, Isabelle, et al.. (2025). The validated French CFAbd‐Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor. Journal of Pediatric Gastroenterology and Nutrition. 82(1). 24–32.
2.
Sermet‐Gaudelus, Isabelle, Annalisa Orenti, Elpis Hatziagorou, et al.. (2025). Health inequity in people with cystic fibrosis: can we close the gap?. Annals of the American Thoracic Society. 23(2). 228–240.
3.
Maule, Giulia, Elise Dréano, Mairead Kelly, et al.. (2024). Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells. Cell Reports Medicine. 5(5). 101544–101544. 35 indexed citations
4.
Villeret, Bérengère, et al.. (2024). Abnormal functional lymphoid tolerance and enhanced myeloid exocytosis are characteristics of resting and stimulated PBMCs in cystic fibrosis patients. Frontiers in Immunology. 15. 1360716–1360716. 3 indexed citations
5.
Kerem, Eitan, et al.. (2024). Cystic fibrosis in Europe: improved lung function and longevity – reasons for cautious optimism, but challenges remain. European Respiratory Journal. 63(3). 2301241–2301241. 15 indexed citations
6.
Pranke, Iwona, Aurélie Hatton, Caroline Faucon, et al.. (2022). The U UGA C sequence provides a favorable context to ELX-02 induced CFTR readthrough. Journal of Cystic Fibrosis. 22(3). 560–563. 11 indexed citations
7.
Zampoli, Marco, Janine Verstraete, Thao Nguyen‐Khoa, et al.. (2022). β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?. Pediatric Pulmonology. 58(1). 187–196. 7 indexed citations
8.
Girard, M, Stéphanie Franchi‐Abella, Laureline Berteloot, et al.. (2021). Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis. Clinics and Research in Hepatology and Gastroenterology. 46(3). 101855–101855. 12 indexed citations
9.
Dréano, Elise, Matthew Bacchetta, Juliette Simonin, et al.. (2019). Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9. SHILAP Revista de lepidopterología. 2(4). 297–311. 29 indexed citations
10.
Tan, Xin, Mathieu Coureuil, Elodie Ramond, et al.. (2019). Chronic Staphylococcus aureus Lung Infection Correlates With Proteogenomic and Metabolic Adaptations Leading to an Increased Intracellular Persistence. Clinical Infectious Diseases. 69(11). 1937–1945. 34 indexed citations
11.
Pranke, Iwona, Laure Bidou, Natacha Martin, et al.. (2018). Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons. ERJ Open Research. 4(1). 80–2017. 36 indexed citations
12.
Saint‐Criq, Vinciane, Bérengère Villeret, Aurélie Hatton, et al.. (2017). Pseudomonas aeruginosaLasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway. Thorax. 73(1). 49–61. 74 indexed citations
13.
Farrell, Philip M., Terry B. White, Clement L. Ren, et al.. (2017). Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. Publisher. 3 indexed citations
14.
Hénaff, Carole Le, Aurélie Hatton, Denis Tondelier, et al.. (2016). Genetic deletion of keratin 8 corrects the altered bone formation and osteopenia in a mouse model of cystic fibrosis. Human Molecular Genetics. 25(7). 1281–1293. 12 indexed citations
15.
Carlon, Marianne, Johanna F. Dekkers, Monika I. Hollenhorst, et al.. (2015). rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice. American Journal of Respiratory and Critical Care Medicine. 193(3). 288–298. 57 indexed citations
16.
Ollero, Mario, Giuseppe Astarita, Ida Chiara Guerrera, et al.. (2011). Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients. Journal of Lipid Research. 52(5). 1011–1022. 60 indexed citations
17.
Sermet‐Gaudelus, Isabelle, K. De Boeck, Georges Casimir, et al.. (2010). Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 182(10). 1262–1272. 184 indexed citations
18.
Bienvenu, Thierry, Isabelle Sermet‐Gaudelus, Pierre‐Régis Burgel, et al.. (2010). Cystic Fibrosis Transmembrane Conductance Regulator Channel Dysfunction in Non–Cystic Fibrosis Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 181(10). 1078–1084. 62 indexed citations
19.
Sermet‐Gaudelus, Isabelle, J.-C. Souberbielle, Jean Charles Ruiz, et al.. (2007). Low Bone Mineral Density in Young Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 175(9). 951–957. 68 indexed citations
20.
Sermet‐Gaudelus, Isabelle, et al.. (2000). Aérosols d’antibiotiques et mucoviscidose. MTP. Médecine thérapeutique pédiatrie. 3(2). 117–124. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce C. Marshall Breakdown of academic impact, for papers by Eitan Kerem Breakdown of academic impact, for papers by Diana Bilton Breakdown of academic impact, for papers by Ronald L. Gibson Breakdown of academic impact, for papers by James R. Yankaskas Breakdown of academic impact, for papers by Frank J. Accurso Breakdown of academic impact, for papers by Noel G. McElvaney Breakdown of academic impact, for papers by Patrick A. Flume Breakdown of academic impact, for papers by Félix Ratjen Breakdown of academic impact, for papers by Michael W. Konstan
Rankless by CCL
2026